Latest News & Updates

Breaking News

  • 9 hours ago

  • Simantini Singh Deo

Serina Therapeutics Strengthens Board With Appointment Of Pharma Executive Farrell Simon
Breaking News
FDA Accepts Revolution Medicines’ Daraxonrasib Application For Advanced Pancreatic Cancer Treatment

Simantini Singh Deo

Other trending news you may like to read

Serina Therapeutics Strengthens Board With Appointment Of Pharma Executive Farrell Simon

Serina Therapeutics strengthens its Board with the appointment of pharma executive Farrell Simon.

Simantini Singh Deo

Pharma Now

FDA Accepts Revolution Medicines’ Daraxonrasib Application For Advanced Pancreatic Cancer Treatment

FDA accepts Revolution Medicines' daraxonrasib application for advanced pancreatic cancer treatment.

Simantini Singh Deo

Pharma Now

NexTel Medical Expands Acquisition To Include Island 40 Group In $12.75 Million Deal

NexTel Medical expands acquisition to include Island 40 Group in a $12.75 million deal.

Simantini Singh Deo

Pharma Now

Spryte Medical Advances Neuro Imaging Program With First INSYTE Trial Participants

Spryte Medical advances neuro imaging program with first INSYTE trial participants.

Simantini Singh Deo

Pharma Now